Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study

In primary prevention, the adipocytokine adiponectin seems to be protective against diabetes mellitus and cardiovascular disease. Data in patients with manifest coronary artery disease (CAD) are scant stimulating the investigation of the association of adiponectin concentrations and cardiovascular outcome in a prospective CAD cohort. In 1890 consecutive patients with documented CAD [1130 with stable angina (SAP) and 760 with acute coronary...